Genetic predisposition influences plasma lipids of participants on habitual diet, but not the response to reductions in dietary intake of saturated fatty acids

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 421-427

  Walker, C G ^a   Loos, R J F ^b   Olson, A D ^a   Frost, G S ^c   Griffin, B A ^d   Lovegrove, J A ^e   Sanders, T A B ^f   Jebb, S A ^a  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e UNIVERSITY OF READING   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dietary saturated fat; Gene diet interaction; Genetic predisposition score; Lipoprotein; Plasma lipids; SNP

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBOHYDRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY MASS; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

ADULT; AGED; APOLIPOPROTEIN A-I; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; DYSLIPIDEMIAS; FATTY ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPIDS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 79953055780     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.039     Document Type: Article

References (31)

1. Kavey R-EW, Daniels S.R., Lauer R.M., et al. American Heart Association Guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003, 107:1562-1566.
2. Jebb S.A., Lovegrove J.A., Griffin B.A., et al. Impact of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK trial. Am J Clin Nutr 2010, 92:748-758.
3. Keys A., Parlin R.W. Serum cholesterol response to changes in dietary lipids. Am J Clin Nutr 1966, 19:175-181.
4. Mensink R.P., Zock P.L., Kester A.D., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
5. Vessby B., Uusitupa M., Hermansen K., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 2001, 44:312-319.
6. Corella D., Ordovas J.M. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 2005, 25:341-390.
7. Uauy R. Dietary fat quality for optimal health and well-being: overview of recommendations. Ann Nutr Metab 2009, 54:2-7.
8. Arking D.E., Chakravarti A. Understanding cardiovascular disease through the lens of genome-wide association studies. Trends Genet 2009, 25:387-394.
9. Aulchenko Y., Ripatti S., Lindqvist I., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009, 41:47-55.
10. Kathiresan S., Manning A., Demissie S., et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet 2007, 8:S17.
11. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008, 40:189-197.
12. Kathiresan S., Willer C.J., Peloso G.M., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 41:56-65.
13. Willer C.J., Sanna S., Jackson A.U., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 40:161-169.
14. Thorleifsson G., Walters G.B., Gudbjartsson D.F., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009, 41:18-24.
15. Wallace C., Newhouse S., Braund P., et al. Genome-wide Association Study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-149.
16. Chasman D., Paré G., Zee R., et al. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet 2008, 1:21-30.
17. Moore C., Gitau R., Goff L., et al. Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model. J Nutr 2009, 139:1534-1540.
18. Talmud P.J., Drenos F., Shah S., et al. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 2009, 85:628-642.
19. Li S., Zhao J.H., Luan Ja., et al. Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am J Clin Nutr 2010, 91:184-190.
20. Hamrefors V., Orho-Melander M., Krauss R.M., et al. A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women. J Lipid Res 2010, 51:625-634.
21. Janssens A.C.J.W., Moonesinghe R., Yang Q., et al. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet. Med. 2007, 9:528-535.
22. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
23. Dattilo A., Kris-Etherton P. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992, 56:320-328.
24. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010, 91:502-509.
25. Santos-Gallego C.G., Ibanez B., Badimon J.J. HDL-cholesterol: is it really good? Differences between apoA-I and HDL. Biochem Pharmacol 2008, 76:443-452.
26. Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
27. Hegele R.A. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 2009, 10:109-121.
28. Lu Y., Dolle M.E.T., Imholz S., et al. Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. J Lipid Res 2008, 49:2582-2589.
29. Chen S., Cilingiroglu M., Todd J., et al. Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet 2009, 10:111.
30. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
31. Neale B.M., Sham P.C. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004, 75:353-362.